Stock ScreenerStock IdeasLow P/E RatioLow P/E Ratio StocksCompanies with P/E ratios below their industry and market average, with a minimum market cap of $250M+
Stock ScreenerStock IdeasLow P/E Ratio
Market Cap: >= $250M
P/E vs Industry: Pass
P/E vs Market: Pass
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MOG.A | MOOG INC | $10.38B | $4.05B | $523.08M | $260.77M | $8.25 | 10.67% | 7.56% | 20.79% | N/A | |||
| STRL | STERLING INFRASTRUCTURE INC | $12.61B | $2.23B | $519.68M | $315.77M | $10.32 | 6.20% | 9.38% | 72.29% | 37.11% | 2026-03-02 | ||
| CORT | CORCEPT THERAPEUTICS INC | $4.19B | $741.17M | $65.98M | $104.65M | $1.00 | 17.92% | 15.79% | -26.47% | 1.03% | |||
| DRS | LEONARDO DRS INC | $10.61B | $3.57B | $426.00M | $265.00M | $1.00 | 12.27% | N/A | 33.33% | N/A | 2026-02-19 | ||
| KRYS | KRYSTAL BIOTECH INC | $8.28B | $389.13M | $196.02M | $204.83M | $7.08 | 33.94% | N/A | 126.92% | N/A | 2026-03-02 | ||
| JBL | JABIL INC | $27.51B | $31.11B | $1.88B | $703.00M | $6.51 | 13.18% | 2.43% | -39.22% | 35.60% | 2026-03-13 | ||
| DY | DYCOM INDUSTRIES INC | $11.95B | $5.17B | $739.13M | $297.57M | $10.28 | 13.19% | 10.18% | 33.68% | 64.25% | 2026-03-04 | ||
| WLDN | WILLDAN GROUP INC | $1.72B | $651.93M | $63.92M | $41.53M | $2.89 | 12.90% | 9.01% | 72.02% | N/A | 2026-02-26 | ||
| ORKA | ORUKA THERAPEUTICS INC | $1.56B | $0.00 | -$101.18M | -$101.63M | $0.80 | N/A | N/A | N/A | N/A | |||
| ACA | ARCOSA INC | $6.04B | $2.83B | $542.10M | $148.60M | $3.03 | 13.96% | 8.05% | 14.77% | 4.69% | 2026-02-26 | ||
| RTX | RTX CORP | $274.91B | $88.60B | $14.52B | $6.73B | $5.02 | 9.74% | 9.38% | 40.22% | N/A | |||
| LHX | L3HARRIS TECHNOLOGIES INC | $65.77B | $21.87B | $3.75B | $1.61B | $8.57 | 2.53% | 3.74% | 8.34% | 10.38% | |||
| ARWR | ARROWHEAD PHARMACEUTICALS INC | $9.02B | $1.09B | $338.91M | $202.27M | $1.56 | 43,539.24% | 68.70% | N/A | N/A | |||
| MMSI | MERIT MEDICAL SYSTEMS INC | $4.92B | $1.48B | $313.03M | $118.43M | $2.01 | 11.41% | 8.91% | -2.90% | N/A | 2026-02-24 | ||
| GILT | GILAT SATELLITE NETWORKS LTD | $947.50M | $451.66M | $47.09M | $20.72M | $0.35 | 47.87% | 22.14% | -20.45% | -11.09% | |||
| BELFA | BEL FUSE INC | $2.62B | $649.38M | $124.18M | $74.10M | $4.94 | 23.70% | 6.92% | 19.90% | 91.86% | |||
| MYRG | MYR GROUP INC | $4.05B | $3.51B | $214.54M | $97.82M | $6.21 | -0.64% | 9.71% | 168.83% | 14.11% | 2026-02-25 | ||
| APH | AMPHENOL CORP | $181.59B | $23.09B | $6.86B | $4.27B | $3.51 | 51.71% | 21.85% | 74.63% | 28.29% | |||
| TDG | TRANSDIGM GROUP INC | $74.28B | $9.11B | $4.63B | $1.81B | $31.10 | 11.67% | 13.93% | 9.66% | 36.89% | |||
| AMAT | APPLIED MATERIALS INC | $292.83B | $28.37B | $9.98B | $7.00B | $8.71 | 4.39% | 10.52% | 0.35% | 17.13% | |||
| STOK | STOKE THERAPEUTICS INC | $1.77B | $205.63M | $31.69M | $40.57M | $0.73 | 1,128.17% | N/A | N/A | N/A | 2026-03-11 | ||
| KLAC | KLA CORP | $194.03B | $12.74B | $5.91B | $4.56B | $34.54 | 17.49% | 15.98% | 44.52% | 31.42% | |||
| SNDR | SCHNEIDER NATIONAL INC | $5.04B | $5.61B | $625.70M | $114.10M | $0.66 | 5.46% | 4.78% | 3.13% | -9.38% | |||
| MBUU | MALIBU BOATS INC | $592.49M | $819.06M | $60.41M | $14.40M | $0.73 | 11.59% | 3.86% | N/A | -26.74% | |||
| DGII | DIGI INTERNATIONAL INC | $1.87B | $448.82M | $95.35M | $42.43M | $1.13 | 6.40% | 9.12% | 15.31% | 33.15% | |||
| COO | COOPER COMPANIES INC | $16.34B | $4.09B | $1.09B | $374.90M | $1.88 | 5.06% | 10.98% | -4.57% | 9.21% | 2026-02-26 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.